Patents by Inventor Chan Sik Kim

Chan Sik Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250105406
    Abstract: The present invention relates to a multilayer film for a secondary battery cell pouch and a manufacturing method therefor and, specifically, to a multilayer film for a secondary battery cell pouch and a manufacturing method therefor, wherein the multilayer film having excellent film characteristics, such as water resistance, airtightness, chemical resistance, strength, surface tension, electrolysis resistance, and heat resistance, is obtained by simultaneously biaxially stretching a laminate, composed of a plurality of resin layers and adhesive layers, at a time. The multilayer film for a secondary battery cell pouch of the present invention is obtained by simultaneously biaxially stretching a multilayer laminate at a time, the multilayer laminate sequentially comprising an upper resin layer, an intermediate resin layer, a lower resin layer, and adhesive layers formed between the respective resin layers.
    Type: Application
    Filed: January 16, 2023
    Publication date: March 27, 2025
    Inventor: Chan Sik KIM
  • Publication number: 20240338314
    Abstract: The present technology relates to an electronic device. According to the present technology, a memory controller may include a garbage collection controller and a sustain detector. The garbage collection controller may generate garbage collection information including valid page count values of victim memory blocks on which garbage collection is to be performed among a plurality of memory blocks included in a memory device. The sustain detector in communication with the garbage collection controller may generate sustain information indicating whether random write performance for the memory device is in a sustain state in which a random write performance value related to a capability of the random write performance is greater than or equal to a threshold value based on the garbage collection information.
    Type: Application
    Filed: September 19, 2023
    Publication date: October 10, 2024
    Inventors: In Sung SONG, Dong Hwan KOO, Ki Tae KIM, Chan Sik KIM, Dong Young SEO, Woong Sik SHIN, In Ho JUNG, Jae Hoon HEO
  • Patent number: 11484562
    Abstract: Provided is a composition for preventing or treating obesity including a mixed extract of Cinnamomi twigs, and more particularly, a pharmaceutical composition for preventing or treating obesity including a mixed extract of Cinnamomi twigs and Moutan root bark, a health functional food composition of feed composition for preventing or alleviating obesity including the composition, and a method of preventing or treating obesity including administering the pharmaceutical composition to an individual having obesity or a risk of developing obesity. The mixed extract of Cinnamomi twigs and Moutan root bark may inhibit fat absorption in the intestinal tract and increases in body weight causing obesity by single-dose administration, reduce lipid content in the blood, decrease weight and size of adipocytes, effectively inhibit accumulation of fat in liver tissue, and inhibit diarrhea, a serious side effect of Xenicalâ„¢, by long-term administration.
    Type: Grant
    Filed: December 11, 2018
    Date of Patent: November 1, 2022
    Assignee: KOREA INSTITUTE OF ORIENTAL MEDICINE
    Inventors: Jin Sook Kim, Chan-Sik Kim, Ik Soo Lee, Gyu Hyung Jo, Soo-Wang Hyun
  • Patent number: 11191801
    Abstract: The extract of a mixture of cinnamon twig and moutan root bark, cinnamon twig and peony root, or cinnamon twig and poria according to the present invention has been confirmed to inhibit the excessive generation of advanced glycation end-products, which occurs under chronic diabetic conditions, exhibit the effect of fragmentizing a cross-link between the advanced glycation end-products and matrix proteins, have an excellent effect in inhibiting the generation of the advanced glycation end-products in a human retinal pigment epithelial cell line subjected to a hyperglycemic or aging environment, and have excellent effects in delaying, preventing, and treating diabetic complications, muscular degeneration, commotio retinae, and lower extremity edema in various animal models of diabetic complications, macular degeneration, and lower extremity edema, and thus the mixture extract can effectively be used as an active ingredient for a composition for preventing and treating diabetic complications, including diabetic
    Type: Grant
    Filed: May 21, 2015
    Date of Patent: December 7, 2021
    Assignee: KOREA INSTITUTE OF ORIENTAL MEDICINE
    Inventors: Jin Sook Kim, Junghyun Kim, Chan-Sik Kim, Eunjin Shon, Yun Mi Lee, Sojin Choi, Ik Soo Lee, Young Sook Kim, Dong Ho Jung, Bo-Jeong Pyun, Seung-Hyun Jung
  • Publication number: 20210113643
    Abstract: Provided is a composition for preventing or treating obesity including a mixed extract of Cinnamomi twigs, and more particularly, a pharmaceutical composition for preventing or treating obesity including a mixed extract of Cinnamomi twigs and Moutan root bark, a health functional food composition of feed composition for preventing or alleviating obesity including the composition, and a method of preventing or treating obesity including administering the pharmaceutical composition to an individual having obesity or a risk of developing obesity. The mixed extract of Cinnamomi twigs and Moutan root bark may inhibit fat absorption in the intestinal tract and increases in body weight causing obesity by single-dose administration, reduce lipid content in the blood, decrease weight and size of adipocytes, effectively inhibit accumulation of fat in liver tissue, and inhibit diarrhea, a serious side effect of Xenicalâ„¢, by long-term administration.
    Type: Application
    Filed: December 11, 2018
    Publication date: April 22, 2021
    Inventors: Jin Sook KIM, Chan-Sik KIM, Ik Soo LEE, Gyu Hyung JO, Soo-Wang HYUN
  • Patent number: 10537603
    Abstract: The present invention relates to a pharmaceutical composition for preventing or treating angioedema, containing as an active ingredient a peony root extract or an extract of a mixture of peony root and licorice. In particular, the extract of a mixture of peony root and licorice according to the present invention inhibits the excessive generation of advanced glycation end products, which may cause macular degeneration, inhibits blood-retinal barrier breakdown causing retinal edema in various animal models, protects or treats a subretinal region causing dry macular degeneration, inhibits angiogenesis causing wet macular degeneration, and thus can be usefully used as an active ingredient for the composition for preventing and treating angioedema including macular degeneration, macular edema, retinal edema, or varicose veins.
    Type: Grant
    Filed: May 21, 2015
    Date of Patent: January 21, 2020
    Assignee: Korea Institute of Oriental Medicine
    Inventors: Jin Sook Kim, Junghyun Kim, Chan-Sik Kim, Eunjin Shon, Yun Mi Lee, Young Sook Kim, Sojin Choi, Ik Soo Lee, Dong Ho Jung, Bo-Jeong Pyun, Seung-Hyun Jung
  • Patent number: 9844575
    Abstract: The present invention relates to a pharmaceutical composition and a health functional food composition for prevention, treatment or amelioration of diabetic complications or angioedema containing a mixed extract of Hedera helix leaves and Coptis chinensis as an active ingredient. More specifically, the present invention relates to a pharmaceutical composition and a health functional food composition for prevention, treatment or amelioration of diabetic complications or angioedema further containing an extract of Rheum palmatum, Puerariae radix, Ginkgo leaves, Cassiae semen, blueberry, bilberry, raspberry, or grape seeds as an active ingredient, in addition to the mixed extract of Hedera helix leaves and Coptis chinensis.
    Type: Grant
    Filed: January 10, 2014
    Date of Patent: December 19, 2017
    Assignee: KOREA INSTITUTE OF ORIENTAL MEDICINE
    Inventors: Jin Sook Kim, Jung Hyun Kim, Chan Sik Kim, Young Sook Kim, Eun Jin Shon, Yun Mi Lee, Dong Ho Jung, Ik Soo Lee, Gyu Hyeong Jo, Joo Hwan Kim
  • Publication number: 20170209510
    Abstract: The present invention relates to a pharmaceutical composition for preventing or treating angioedema, containing as an active ingredient a peony root extract or an extract of a mixture of peony root and licorice. In particular, the extract of a mixture of peony root and licorice according to the present invention inhibits the excessive generation of advanced glycation end products, which may cause macular degeneration, inhibits blood-retinal barrier breakdown causing retinal edema in various animal models, protects or treats a subretinal region causing dry macular degeneration, inhibits angiogenesis causing wet macular degeneration, and thus can be usefully used as an active ingredient for the composition for preventing and treating angioedema including macular degeneration, macular edema, retinal edema, or varicose veins.
    Type: Application
    Filed: May 21, 2015
    Publication date: July 27, 2017
    Inventors: Jin Sook KIM, Junghyun KIM, Chan-Sik KIM, Eunjin SHON, Yun Mi LEE, Young Sook KIM, Sojin CHOI, Ik Soo LEE, Dong Ho JUNG, Bo-Jeong PYUN, Seung-Hyun JUNG
  • Publication number: 20170182107
    Abstract: The extract of a mixture of cinnamon twig and moutan root bark, cinnamon twig and peony root, or cinnamon twig and poria according to the present invention has been confirmed to inhibit the excessive generation of advanced glycation end-products, which occurs under chronic diabetic conditions, exhibit the effect of fragmentizing a cross-link between the advanced glycation end-products and matrix proteins, have an excellent effect in inhibiting the generation of the advanced glycation end-products in a human retinal pigment epithelial cell line subjected to a hyperglycemic or aging environment, and have excellent effects in delaying, preventing, and treating diabetic complications, muscular degeneration, commotio retinae, and lower extremity edema in various animal models of diabetic complications, macular degeneration, and lower extremity edema, and thus the mixture extract can effectively be used as an active ingredient for a composition for preventing and treating diabetic complications, including diabetic
    Type: Application
    Filed: May 21, 2015
    Publication date: June 29, 2017
    Inventors: Jin Sook KIM, Junghyun KIM, Chan-Sik KIM, Eunjin SHON, Yun Mi LEE, Sojin CHOI, Ik Soo LEE, Young Sook KIM, Dong Ho JUNG, Bo-Jeong PYUN, Seung-Hyun JUNG
  • Patent number: 9504725
    Abstract: The present invention relates to the obesity-curative or obesity-preventive effect of a Polygonum cuspidatum butanol fraction and a Polygonum cuspidatum ethylacetate fraction, and more particularly, to a pharmaceutical composition and a functional food for treating obesity, the pharmaceutical composition and the functional food comprising a Polygonum cuspidatum butanol fraction (POCU-1b) and an ethylacetate fraction as active ingredients, wherein the Polygonum cuspidatum butanol fraction and the ethylacetate fraction inhibit effectively the activity of pancreatic lipase, an important enzyme involving in fat absorption in a living body, and have excellent inhibitory effect on fat absorption in the short term fat absorption-inhibitory animal experiments using lipid emulsions.
    Type: Grant
    Filed: December 29, 2009
    Date of Patent: November 29, 2016
    Assignee: KOREA INSTITUTE OF ORIENTAL MEDICINE
    Inventors: Jin Sook Kim, Dae Sik Jang, Young Sook Kim, Junghyun Kim, Chan-Sik Kim
  • Patent number: 9446081
    Abstract: The present invention relates to a pharmaceutical composition for the prevention and treatment of diabetic complications comprising the extract of Homonoia riparia Lour. or the fraction thereof as an active ingredient. More particularly, the extract of Homonoia riparia Lour. or the fractions thereof of the present invention can inhibit the activity of aldose reductase and the generation of the advanced glycation endproducts, the index of diabetic complications, and have powerful activity of inhibiting diabetic complications with brining the anti-cataract, anti-retinopathy, and anti-neuropathy effect, and have the activity of anti-oxidation as well, so that they can be effectively used as an active ingredient of a pharmaceutical composition for the prevention and treatment of diabetic complications.
    Type: Grant
    Filed: March 7, 2011
    Date of Patent: September 20, 2016
    Assignee: KOREA INSTITUTE OF ORIENTAL MEDICINE
    Inventors: Jin Sook Kim, I, Jung Hyun Kim, Young Sook Kim, Chan-Sik Kim, Ohn Soon Kim, Eun Jin Shon, Nam-Hee Yoo, Yun Mi Lee, Dong Ho Jung
  • Patent number: 9248409
    Abstract: Provided is a hollow-fiber membrane module comprising a submodule inside which raw water is circulated and water treatment is carried out, and a piping unit which is connected to the submodule and through which the raw water and air and treated water flow, such that flow rates can be increased and energy consumption can be minimized through the circulation of a fluid.
    Type: Grant
    Filed: January 27, 2011
    Date of Patent: February 2, 2016
    Assignee: Woongjin Coway, Co. Ltd.
    Inventors: Soo-Hong Noh, Oh-Sung Kwon, Young-Keun Choi, Chan-Sik Kim, Seung-Il Lee, Woo-Seung Choi
  • Publication number: 20150343005
    Abstract: The present invention relates to a pharmaceutical composition and a health functional food composition for prevention, treatment or amelioration of diabetic complications or angioedema containing a mixed extract of Hedera helix leaves and Coptis chinensis as an active ingredient. More specifically, the present invention relates to a pharmaceutical composition and a health functional food composition for prevention, treatment or amelioration of diabetic complications or angioedema further containing an extract of Rheum palmatum, Puerariae radix, Ginkgo leaves, Cassiae semen, blueberry, bilberry, raspberry, or grape seeds as an active ingredient, in addition to the mixed extract of Hedera helix leaves and Coptis chinensis.
    Type: Application
    Filed: January 10, 2014
    Publication date: December 3, 2015
    Inventors: Jin Sook KIM, Jung Hyun KIM, Chan Sik KIM, Young Sook KIM, Eun Jin SHON, Yun Mi LEE, Dong Ho JUNG, Ik Soo LEE, Gyu Hyeong JO, Joo Hwan KIM
  • Patent number: 8784911
    Abstract: The present invention relates to a treatment agent for diabetic complications, and a method for the treatment of diabetic complications using the same. The present invention confirmed that Osteomeles schwerinae extract and its fractions inhibited the generation of AGEs, the index for diabetic complications, inhibited the activation of aldose reductase, had anti-cataract activity, and had anti-oxidative activity. Thus, the present invention relates to a preventive and therapeutic agent for diabetic complications containing the said Osteomeles schwerinae extract and its fraction as an active ingredient.
    Type: Grant
    Filed: November 5, 2009
    Date of Patent: July 22, 2014
    Assignee: Korea Institute of Oriental Medicine
    Inventors: Jin Sook Kim, Dae Sik Jang, Young Sook Kim, Yun Mi Lee, Joo-Hwan Kim, Eunjin Shon, Junghyun Kim, Chan-Sik Kim, Dong Ho Jung, Nan Hee Kim, Nam-Hee Yoo, Jun Lee
  • Patent number: 8785503
    Abstract: The present invention provides a novel biphenyl compound or pharmaceutically acceptable salts thereof, methods for preparing the same, and pharmaceutical compositions for preventing or treating diabetic complications containing the same as an active ingredient. Novel biphenyl compounds, according to the present invention, effectively suppress generation activity of advanced glycation end products, which cause diabetic complications and are a criterion for evaluating the effectiveness of a treating agent for diabetic complications, and show an excellent therapeutic effect on retina blood vessels, increased occludin, and decreased angiogenic growth factor in actual diabetic retinopathy induced retina. Thus, novel biphenyl compounds according to the present invention can be used effectively as an active ingredient in compositions for preventing or treating diabetic complications such as diabetic retinopathy.
    Type: Grant
    Filed: August 11, 2011
    Date of Patent: July 22, 2014
    Assignee: Korea Institute of Oriental Medicine
    Inventors: Jin Sook Kim, Young Sook Kim, Jung Hyun Kim, Eun Jin Shon, Ki Mo Kim, Chan-Sik Kim, Dong Ho Jung, Yun Mi Lee, Kyu Hyung Jo, Ohn Soon Kim, Nam-Hee Yoo
  • Publication number: 20130316030
    Abstract: The present invention relates to a pharmaceutical composition for the prevention and treatment of diabetic complications comprising the extract of Homonoia riparia Lour. or the fraction thereof as an active ingredient. More particularly, the extract of Homonoia riparia Lour. or the fractions thereof of the present invention can inhibit the activity of aldose reductase and the generation of the advanced glycation endproducts, the index of diabetic complications, and have powerful activity of inhibiting diabetic complications with brining the anti-cataract, anti-retinopathy, and anti-neuropathy effect, and have the activity of anti-oxidation as well, so that they can be effectively used as an active ingredient of a pharmaceutical composition for the prevention and treatment of diabetic complications.
    Type: Application
    Filed: March 7, 2011
    Publication date: November 28, 2013
    Applicant: KOREA INSTITUTE OF ORIENTAL MEDICINE
    Inventors: Jin Sook Kim, Jung Hyun Kim, Young Sook Kim, Chan-Sik Kim, Ohn Soon Kim, Eun Jin Shon, Nam-Hee Yoo, Yun Mi Lee, Dong Ho Jung
  • Publication number: 20130210928
    Abstract: The present invention provides a novel biphenyl compound or pharmaceutically acceptable salts thereof, methods for preparing the same, and pharmaceutical compositions for preventing or treating diabetic complications containing the same as an active ingredient. Novel biphenyl compounds, according to the present invention, effectively suppress generation activity of advanced glycation end products, which cause diabetic complications and are a criterion for evaluating the effectiveness of a treating agent for diabetic complications, and show an excellent therapeutic effect on retina blood vessels, increased occludin, and decreased angiogenic growth factor in actual diabetic retinopathy induced retina. Thus, novel biphenyl compounds according to the present invention can be used effectively as an active ingredient in compositions for preventing or treating diabetic complications such as diabetic retinopathy.
    Type: Application
    Filed: August 11, 2011
    Publication date: August 15, 2013
    Applicant: KOREA INSTITUTE OF ORIENTAL MEDICINE
    Inventors: Jin Sook Kim, Young Sook Kim, Jung Hyun Kim, Eun Jin Shon, Ki Mo Kim, Chan-sik Kim, Dong Ho Jung, Yun Mi Lee, Kyu Hyung Jo, Ohn Soon Kim, Nam-Hee Yoo
  • Patent number: 8397850
    Abstract: Disclosed are a driving system and method of a hybrid electric vehicle. The hybrid electric vehicle driving system includes a generator to generate electric energy from rotating power input thereto, and an electric motor to generate rotating power from electric energy supplied thereto. An auxiliary drive wheel is movably provided to be raised or lowered. When being lowered, the auxiliary drive wheel is rotated in contact with the ground surface, to provide the generator with rotating power generated upon rotation thereof. A power distributor is provided to distribute the rotating power generated from the electric motor or auxiliary drive wheel, so as to provide the generator with regenerative energy, or to provide a drive wheel with rotating power. A control unit controls distribution of the rotating power by controlling the supply of electric current to the power distributor.
    Type: Grant
    Filed: November 10, 2008
    Date of Patent: March 19, 2013
    Inventor: Chan-sik Kim
  • Publication number: 20120292248
    Abstract: Provided is a hollow-fibre membrane module comprising a submodule inside which raw water is circulated and water treatment is carried out, and a piping unit which is connected to the submodule and through which the raw water and air and treated water flow, such that flow rates can be increased and energy consumption can be minimised through the circulation of a fluid, and the advantages of internal-pressure type and external-pressure type systems can be incorporated in a composite fashion.
    Type: Application
    Filed: January 27, 2011
    Publication date: November 22, 2012
    Applicant: Woongjin Coway, Co. Ltd.
    Inventors: Soo-Hong Noh, Oh-Sung Kwon, Young-Keun Choi, Chan-Sik Kim, Seung-Il Lee, Woo-Seung Choi
  • Publication number: 20120183633
    Abstract: The present invention relates to the obesity-curative or obesity-preventive effect of a Polygonum cuspidatum butanol fraction and a Polygonum cuspidatum ethylacetate fraction, and more particularly, to a pharmaceutical composition and a functional food for treating obesity, the pharmaceutical composition and the functional food comprising a Polygonum cuspidatum butanol fraction (POCU-1b) and an ethylacetate fraction as active ingredients, wherein the Polygonum cuspidatum butanol fraction and the ethylacetate fraction inhibit effectively the activity of pancreatic lipase, an important enzyme involving in fat absorption in a living body, and have excellent inhibitory effect on fat absorption in the short term fat absorption-inhibitory animal experiments using lipid emulsions.
    Type: Application
    Filed: December 29, 2009
    Publication date: July 19, 2012
    Applicant: KOREA INSTITUTE OF ORIENTAL MEDICINE
    Inventors: Jin Sook Kim, Dae Sik Jang, Young Sook Kim, Junghyun Kim, Chan-Sik Kim